The Biotech Growth Trust PLC


The Biotech Growth Trust PLC

  • Price (GBX)1,126.00
  • Today's Change-22.00 / -1.92%
  • Shares traded53.78k
  • 1 Year change-25.43%
  • Beta0.8066
Data delayed at least 20 minutes, as of Dec 03 2021 16:35 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Mar 31 2021202120202019
Cash And Short Term Investments1.50----
Total Receivables, Net------
Total Inventory------
Prepaid expenses0.040.040.02
Other current assets, total4.732.490.04
Total current assets6.262.530.06
Property, plant & equipment, net------
Goodwill, net------
Intangibles, net------
Long term investments643399431
Note receivable - long term------
Other long term assets------
Total assets650401431
Accounts payable------
Accrued expenses18----
Notes payable/short-term debt273311
Current portion long-term debt/capital leases------
Other current liabilities, total1.981.8210
Total current liabilities483622
Total long term debt000
Total debt273311
Deferred income tax------
Minority interest------
Other liabilities, total------
Total liabilities483622
Common stock109.8013
Additional paid-in capital784343
Retained earnings (accumulated deficit)513313353
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity601366409
Total liabilities & shareholders' equity650401431
Total common shares outstanding423952
Treasury shares - common primary issue000
An LSEG Business
All markets data located on is subject to the FT Terms & Conditions
All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.